Literature DB >> 21958927

Comparison of air-Q(®) and Soft Seal(®) laryngeal mask for airway management by novice doctors during infant chest compression: a manikin study.

Nobuyasu Komasawa1, Ryusuke Ueki, Noriyasu Yamamoto, Kazuaki Atagi, Shin-ichi Nishi, Yoshiroh Kaminoh, Chikara Tashiro.   

Abstract

BACKGROUND: Recent resuscitation guidelines for infant cardiopulmonary resuscitation (CPR) emphasise that rescuers should minimise the interruption of chest compressions. To that end, supraglottic devices such as laryngeal mask airways (LMAs) are suggested as a backup for airway management during infant CPR. We therefore compared the utility of the air-Q(®) LMA (air-Q) with that of the Soft Seal(®) LMA (Soft Seal) for infant CPR in an infant manikin.
METHODS: Twenty-four novice doctors in the anaesthesia department performed insertion and ventilation with air-Q and Soft Seal on an infant manikin with or without chest compression.
RESULTS: Two doctors failed to insert the Soft Seal without chest compression, while nine failed during chest compression (P<0.05). However, only one doctor failed to insert the air-Q without chest compression, and two doctors failed during chest compression. Insertion time was not significantly increased with chest compression using either device. Insertion time during chest compression was significantly shorter for the air-Q than for the Soft Seal (P<0.05). The visual analogue scale (VAS) was used to evaluate difficulty of use (0mm (extremely easy) to 100mm (extremely difficult)). VAS scores did not change significantly by the addition of chest compression with either device; however, VAS scores during chest compression were significantly higher with Soft Seal than with the air-Q device.
CONCLUSION: We conclude that novice doctors find the air-Q easier to use than Soft Seal for emergency airway management during chest compression in infants, in an infant manikin. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21958927     DOI: 10.1016/j.resuscitation.2011.08.025

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

1.  Muscle relaxant effects on insertion efficacy of the laryngeal mask ProSeal(®) in anesthetized patients: a prospective randomized controlled trial.

Authors:  Atsushi Fujiwara; Nobuyasu Komasawa; Isao Nishihara; Shinichiro Miyazaki; Shinichi Tatsumi; Wataru Nishimura; Toshiaki Minami
Journal:  J Anesth       Date:  2015-02-10       Impact factor: 2.078

2.  Evaluation of the efficacy of six supraglottic devices for airway management in dark conditions: a crossover randomized simulation trial.

Authors:  Fumihiro Ohchi; Nobuyasu Komasawa; Kentaro Imagawa; Kaori Okamoto; Toshiaki Minami
Journal:  J Anesth       Date:  2015-07-24       Impact factor: 2.078

3.  Evaluation of chest compression effect on airway management with air-Q, aura-i, i-gel, and Fastrack intubating supraglottic devices by novice physicians: a randomized crossover simulation study.

Authors:  Nobuyasu Komasawa; Ryusuke Ueki; Yoshiroh Kaminoh; Shin-Ichi Nishi
Journal:  J Anesth       Date:  2014-02-22       Impact factor: 2.078

4.  Comparison of positional shift of supraglottic devices resulting from chest compressions: simulation using a manikin and automated chest compression system.

Authors:  Manabu Kitano; Nobuyasu Komasawa; Shunsuke Fujiwara; Toshiaki Minami
Journal:  Acute Med Surg       Date:  2014-10-20

5.  Does prewarming the i-gel supraglottic airway device fit the larynx better compared to keeping it at room temperature for non-paralysed, sedated patients: a randomised controlled trial.

Authors:  Nobuyasu Komasawa; Isao Nishihara; Shinichi Tatsumi; Toshiaki Minami
Journal:  BMJ Open       Date:  2015-01-13       Impact factor: 2.692

6.  Utility of a gum-elastic bougie for difficult airway management in infants: a simulation-based crossover analysis.

Authors:  Nobuyasu Komasawa; Akira Hyoda; Sayuri Matsunami; Nozomi Majima; Toshiaki Minami
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.